Specific  ||| S:0 E:9 ||| JJ
immuno-extraction  ||| S:9 E:27 ||| NN
followed  ||| S:27 E:36 ||| VBN
by  ||| S:36 E:39 ||| IN
enzymatic  ||| S:39 E:49 ||| JJ
detection  ||| S:49 E:59 ||| NNS
( ||| S:59 E:60 ||| -LRB-
SIEFED ||| S:60 E:66 ||| NNP
)  ||| S:66 E:68 ||| -RRB-
of  ||| S:68 E:71 ||| IN
myeloperoxidase  ||| S:71 E:87 ||| NN
and  ||| S:87 E:91 ||| CC
mitochondrial  ||| S:91 E:105 ||| JJ
complex  ||| S:105 E:113 ||| NN
I  ||| S:113 E:115 ||| PRP
in  ||| S:115 E:118 ||| IN
muscular  ||| S:118 E:127 ||| JJ
microbiopsies ||| S:127 E:140 ||| NN
:  ||| S:140 E:142 ||| :
preliminary  ||| S:142 E:154 ||| JJ
results  ||| S:154 E:162 ||| NNS
in  ||| S:162 E:165 ||| IN
endurance  ||| S:165 E:175 ||| JJ
horses  ||| S:175 E:182 ||| NNS
Intense  ||| S:182 E:190 ||| JJ
exercise  ||| S:190 E:199 ||| NN
in  ||| S:199 E:202 ||| IN
horses  ||| S:202 E:209 ||| NNS
induces  ||| S:209 E:217 ||| VBZ
an  ||| S:217 E:220 ||| DT
increase  ||| S:220 E:229 ||| NN
of  ||| S:229 E:232 ||| IN
creatine  ||| S:232 E:241 ||| JJ
kinase  ||| S:241 E:248 ||| NNS
( ||| S:248 E:249 ||| -LRB-
CK ||| S:249 E:251 ||| NNP
)  ||| S:251 E:253 ||| -RRB-
and  ||| S:253 E:257 ||| CC
stimulation  ||| S:257 E:269 ||| NN
of  ||| S:269 E:272 ||| IN
neutrophils  ||| S:272 E:284 ||| NNS
which  ||| S:284 E:290 ||| WDT
release  ||| S:290 E:298 ||| VBP
the  ||| S:298 E:302 ||| DT
strong  ||| S:302 E:309 ||| JJ
oxidant  ||| S:309 E:317 ||| JJ
enzyme ||| S:317 E:323 ||| NN
,  ||| S:323 E:325 ||| ,
myeloperoxidase  ||| S:325 E:341 ||| NNS
( ||| S:341 E:342 ||| -LRB-
MPO ||| S:342 E:345 ||| NNP
)  ||| S:345 E:347 ||| -RRB-
into  ||| S:347 E:352 ||| IN
the  ||| S:352 E:356 ||| DT
blood ||| S:356 E:361 ||| NN
.  ||| S:361 E:363 ||| .
It  ||| S:363 E:366 ||| PRP
is  ||| S:366 E:369 ||| VBZ
not  ||| S:369 E:373 ||| RB
known  ||| S:373 E:379 ||| VBN
whether  ||| S:379 E:387 ||| IN
active  ||| S:387 E:394 ||| JJ
MPO  ||| S:394 E:398 ||| NNP
is  ||| S:398 E:401 ||| VBZ
found  ||| S:401 E:407 ||| VBN
in  ||| S:407 E:410 ||| IN
equine  ||| S:410 E:417 ||| JJ
muscles  ||| S:417 E:425 ||| NNS
and  ||| S:425 E:429 ||| CC
whether  ||| S:429 E:437 ||| IN
oxidant  ||| S:437 E:445 ||| JJ
activity  ||| S:445 E:454 ||| NN
of  ||| S:454 E:457 ||| IN
neutrophils  ||| S:457 E:469 ||| NNS
could  ||| S:469 E:475 ||| MD
affect  ||| S:475 E:482 ||| VB
muscular  ||| S:482 E:491 ||| JJ
tissues  ||| S:491 E:499 ||| NNS
and  ||| S:499 E:503 ||| CC
mitochondrial  ||| S:503 E:517 ||| JJ
activity ||| S:517 E:525 ||| NN
.  ||| S:525 E:527 ||| .
Specific  ||| S:527 E:536 ||| JJ
immuno-extraction  ||| S:536 E:554 ||| NN
followed  ||| S:554 E:563 ||| VBN
by  ||| S:563 E:566 ||| IN
enzymatic  ||| S:566 E:576 ||| JJ
detection  ||| S:576 E:586 ||| NNS
( ||| S:586 E:587 ||| -LRB-
SIEFED ||| S:587 E:593 ||| NNP
)  ||| S:593 E:595 ||| -RRB-
methods  ||| S:595 E:603 ||| NNS
will  ||| S:603 E:608 ||| MD
be  ||| S:608 E:611 ||| VB
employed  ||| S:611 E:620 ||| VBN
for  ||| S:620 E:624 ||| IN
the  ||| S:624 E:628 ||| DT
first  ||| S:628 E:634 ||| JJ
time  ||| S:634 E:639 ||| NN
to  ||| S:639 E:642 ||| TO
assess  ||| S:642 E:649 ||| VB
both  ||| S:649 E:654 ||| PDT
the  ||| S:654 E:658 ||| DT
normal  ||| S:658 E:665 ||| JJ
range  ||| S:665 E:671 ||| NN
of  ||| S:671 E:674 ||| IN
MPO  ||| S:674 E:678 ||| NNP
and  ||| S:678 E:682 ||| CC
mitochondrial  ||| S:682 E:696 ||| JJ
complex  ||| S:696 E:704 ||| NN
I  ||| S:704 E:706 ||| PRP
( ||| S:706 E:707 ||| -LRB-
MCI ||| S:707 E:710 ||| NNP
)  ||| S:710 E:712 ||| -RRB-
activities  ||| S:712 E:723 ||| NNS
in  ||| S:723 E:726 ||| IN
equine  ||| S:726 E:733 ||| JJ
muscular  ||| S:733 E:742 ||| JJ
microbiopsies  ||| S:742 E:756 ||| NN
and  ||| S:756 E:760 ||| CC
to  ||| S:760 E:763 ||| TO
study  ||| S:763 E:769 ||| VB
the  ||| S:769 E:773 ||| DT
variation  ||| S:773 E:783 ||| NN
of  ||| S:783 E:786 ||| IN
these  ||| S:786 E:792 ||| DT
activities  ||| S:792 E:803 ||| NNS
induced  ||| S:803 E:811 ||| VBN
by  ||| S:811 E:814 ||| IN
endurance  ||| S:814 E:824 ||| JJ
races ||| S:824 E:829 ||| NNS
.  ||| S:829 E:831 ||| .
Forty-six  ||| S:831 E:841 ||| JJ
microbiopsies  ||| S:841 E:855 ||| NN
were  ||| S:855 E:860 ||| VBD
taken  ||| S:860 E:866 ||| VBN
from  ||| S:866 E:871 ||| IN
8  ||| S:871 E:873 ||| CD
endurance  ||| S:873 E:883 ||| CD
Arabian  ||| S:883 E:891 ||| JJ
horses  ||| S:891 E:898 ||| NNS
( ||| S:898 E:899 ||| -LRB-
age ||| S:899 E:902 ||| NN
:  ||| S:902 E:904 ||| :
10  ||| S:904 E:907 ||| CD
±  ||| S:907 E:909 ||| CD
2  ||| S:909 E:911 ||| CD
years ||| S:911 E:916 ||| NNS
)  ||| S:916 E:918 ||| -RRB-
in  ||| S:918 E:921 ||| IN
the  ||| S:921 E:925 ||| DT
triceps  ||| S:925 E:933 ||| JJ
brachii  ||| S:933 E:941 ||| NNS
( ||| S:941 E:942 ||| -LRB-
n  ||| S:942 E:944 ||| CD
=  ||| S:944 E:946 ||| SYM
23 ||| S:946 E:948 ||| CD
)  ||| S:948 E:950 ||| -RRB-
or  ||| S:950 E:953 ||| CC
in  ||| S:953 E:956 ||| IN
the  ||| S:956 E:960 ||| DT
gluteus  ||| S:960 E:968 ||| JJ
medius  ||| S:968 E:975 ||| JJ
muscle  ||| S:975 E:982 ||| NN
( ||| S:982 E:983 ||| -LRB-
n  ||| S:983 E:985 ||| CD
=  ||| S:985 E:987 ||| SYM
23 ||| S:987 E:989 ||| CD
) ||| S:989 E:990 ||| -RRB-
.  ||| S:990 E:992 ||| .
Myeloperoxidase  ||| S:992 E:1008 ||| NNP
and  ||| S:1008 E:1012 ||| CC
MCI  ||| S:1012 E:1016 ||| NNP
activities  ||| S:1016 E:1027 ||| NNS
were  ||| S:1027 E:1032 ||| VBD
measured  ||| S:1032 E:1041 ||| VBN
in  ||| S:1041 E:1044 ||| IN
muscle  ||| S:1044 E:1051 ||| NN
extracts  ||| S:1051 E:1060 ||| NN
by  ||| S:1060 E:1063 ||| IN
enzyme  ||| S:1063 E:1070 ||| JJ
immunocapture  ||| S:1070 E:1084 ||| JJ
assays  ||| S:1084 E:1091 ||| NN
or  ||| S:1091 E:1094 ||| CC
SIEFED  ||| S:1094 E:1101 ||| NNP
methods ||| S:1101 E:1108 ||| NNS
.  ||| S:1108 E:1110 ||| .
Further ||| S:1110 E:1117 ||| RB
,  ||| S:1117 E:1119 ||| ,
7  ||| S:1119 E:1121 ||| CD
endurance  ||| S:1121 E:1131 ||| CD
horses  ||| S:1131 E:1138 ||| NNS
were  ||| S:1138 E:1143 ||| VBD
sampled  ||| S:1143 E:1151 ||| VBN
in  ||| S:1151 E:1154 ||| IN
the  ||| S:1154 E:1158 ||| DT
triceps  ||| S:1158 E:1166 ||| JJ
brachii  ||| S:1166 E:1174 ||| JJ
muscle  ||| S:1174 E:1181 ||| NN
before  ||| S:1181 E:1188 ||| IN
( ||| S:1188 E:1189 ||| -LRB-
T0 ||| S:1189 E:1191 ||| NNP
)  ||| S:1191 E:1193 ||| -RRB-
and  ||| S:1193 E:1197 ||| CC
after  ||| S:1197 E:1203 ||| IN
( ||| S:1203 E:1204 ||| -LRB-
T1 ||| S:1204 E:1206 ||| NNP
)  ||| S:1206 E:1208 ||| -RRB-
a  ||| S:1208 E:1210 ||| DT
120  ||| S:1210 E:1214 ||| CD
km  ||| S:1214 E:1217 ||| CD
endurance  ||| S:1217 E:1227 ||| JJ
race  ||| S:1227 E:1232 ||| NN
( ||| S:1232 E:1233 ||| -LRB-
mean  ||| S:1233 E:1238 ||| JJ
speed ||| S:1238 E:1243 ||| NN
:  ||| S:1243 E:1245 ||| :
15.4  ||| S:1245 E:1250 ||| CD
±  ||| S:1250 E:1252 ||| CD
1.4  ||| S:1252 E:1256 ||| CD
km ||| S:1256 E:1258 ||| CD
/ ||| S:1258 E:1259 ||| CD
h ||| S:1259 E:1260 ||| CD
) ||| S:1260 E:1261 ||| -RRB-
.  ||| S:1261 E:1263 ||| .
The  ||| S:1263 E:1267 ||| DT
46  ||| S:1267 E:1270 ||| CD
microbiopsies  ||| S:1270 E:1284 ||| NN
from  ||| S:1284 E:1289 ||| IN
8  ||| S:1289 E:1291 ||| CD
horses  ||| S:1291 E:1298 ||| NNS
revealed  ||| S:1298 E:1307 ||| VBD
mean  ||| S:1307 E:1312 ||| JJ
values  ||| S:1312 E:1319 ||| NNS
for  ||| S:1319 E:1323 ||| IN
active  ||| S:1323 E:1330 ||| JJ
MPO  ||| S:1330 E:1334 ||| NNP
concentration  ||| S:1334 E:1348 ||| NN
and  ||| S:1348 E:1352 ||| CC
MCI  ||| S:1352 E:1356 ||| NNP
activity  ||| S:1356 E:1365 ||| NN
of  ||| S:1365 E:1368 ||| IN
21  ||| S:1368 E:1371 ||| CD
±  ||| S:1371 E:1373 ||| CD
14  ||| S:1373 E:1376 ||| CD
ng ||| S:1376 E:1378 ||| CD
/ ||| S:1378 E:1379 ||| CD
mg  ||| S:1379 E:1382 ||| CD
proteins  ||| S:1382 E:1391 ||| NNS
and  ||| S:1391 E:1395 ||| CC
0.0172  ||| S:1395 E:1402 ||| FW
±  ||| S:1402 E:1404 ||| FW
0.0066  ||| S:1404 E:1411 ||| FW
mOD ||| S:1411 E:1414 ||| FW
/ ||| S:1414 E:1415 ||| FW
min ||| S:1415 E:1418 ||| FW
/ ||| S:1418 E:1419 ||| FW
μg  ||| S:1419 E:1422 ||| FW
proteins ||| S:1422 E:1430 ||| FW
,  ||| S:1430 E:1432 ||| ,
respectively ||| S:1432 E:1444 ||| RB
.  ||| S:1444 E:1446 ||| .
No  ||| S:1446 E:1449 ||| DT
significant  ||| S:1449 E:1461 ||| JJ
difference  ||| S:1461 E:1472 ||| NN
was  ||| S:1472 E:1476 ||| VBD
observed  ||| S:1476 E:1485 ||| VBN
between  ||| S:1485 E:1493 ||| IN
the  ||| S:1493 E:1497 ||| DT
2  ||| S:1497 E:1499 ||| CD
muscles ||| S:1499 E:1506 ||| NNS
.  ||| S:1506 E:1508 ||| .
In  ||| S:1508 E:1511 ||| IN
3  ||| S:1511 E:1513 ||| CD
out  ||| S:1513 E:1517 ||| IN
of  ||| S:1517 E:1520 ||| IN
the  ||| S:1520 E:1524 ||| DT
7  ||| S:1524 E:1526 ||| CD
horses  ||| S:1526 E:1533 ||| NNS
sampled  ||| S:1533 E:1541 ||| VBN
after  ||| S:1541 E:1547 ||| IN
exercise ||| S:1547 E:1555 ||| NN
,  ||| S:1555 E:1557 ||| ,
the  ||| S:1557 E:1561 ||| DT
120  ||| S:1561 E:1565 ||| CD
km  ||| S:1565 E:1568 ||| CD
endurance  ||| S:1568 E:1578 ||| JJ
race  ||| S:1578 E:1583 ||| NN
induced  ||| S:1583 E:1591 ||| VBD
a  ||| S:1591 E:1593 ||| DT
severe  ||| S:1593 E:1600 ||| JJ
increase  ||| S:1600 E:1609 ||| NN
of  ||| S:1609 E:1612 ||| IN
muscle  ||| S:1612 E:1619 ||| NN
MPO  ||| S:1619 E:1623 ||| NNP
activity  ||| S:1623 E:1632 ||| NN
( ||| S:1632 E:1633 ||| -LRB-
+118  ||| S:1633 E:1638 ||| CD
±  ||| S:1638 E:1640 ||| CD
45 ||| S:1640 E:1642 ||| CD
%  ||| S:1642 E:1644 ||| NN
vs.  ||| S:1644 E:1648 ||| IN
T0 ||| S:1648 E:1650 ||| CD
) ||| S:1650 E:1651 ||| -RRB-
,  ||| S:1651 E:1653 ||| ,
a  ||| S:1653 E:1655 ||| DT
large  ||| S:1655 E:1661 ||| JJ
decrease  ||| S:1661 E:1670 ||| NN
of  ||| S:1670 E:1673 ||| IN
MCI  ||| S:1673 E:1677 ||| NNP
activity  ||| S:1677 E:1686 ||| NN
( ||| S:1686 E:1687 ||| -LRB-
-63  ||| S:1687 E:1691 ||| CD
±  ||| S:1691 E:1693 ||| CD
18 ||| S:1693 E:1695 ||| CD
%  ||| S:1695 E:1697 ||| NN
vs.  ||| S:1697 E:1701 ||| IN
T0 ||| S:1701 E:1703 ||| CD
)  ||| S:1703 E:1705 ||| -RRB-
associated  ||| S:1705 E:1716 ||| VBN
with  ||| S:1716 E:1721 ||| IN
a  ||| S:1721 E:1723 ||| DT
high  ||| S:1723 E:1728 ||| JJ
mean  ||| S:1728 E:1733 ||| JJ
plasma  ||| S:1733 E:1740 ||| JJ
CK  ||| S:1740 E:1743 ||| NNP
level  ||| S:1743 E:1749 ||| NN
( ||| S:1749 E:1750 ||| -LRB-
4642  ||| S:1750 E:1755 ||| CD
±  ||| S:1755 E:1757 ||| CD
658  ||| S:1757 E:1761 ||| CD
iu ||| S:1761 E:1763 ||| CD
/ ||| S:1763 E:1764 ||| CD
l ||| S:1764 E:1765 ||| CD
) ||| S:1765 E:1766 ||| -RRB-
.  ||| S:1766 E:1768 ||| .
In  ||| S:1768 E:1771 ||| IN
the  ||| S:1771 E:1775 ||| DT
4  ||| S:1775 E:1777 ||| CD
remaining  ||| S:1777 E:1787 ||| JJ
horses ||| S:1787 E:1793 ||| NNS
,  ||| S:1793 E:1795 ||| ,
the  ||| S:1795 E:1799 ||| DT
120  ||| S:1799 E:1803 ||| CD
km  ||| S:1803 E:1806 ||| CD
endurance  ||| S:1806 E:1816 ||| JJ
race  ||| S:1816 E:1821 ||| NN
did  ||| S:1821 E:1825 ||| VBD
not  ||| S:1825 E:1829 ||| RB
modify  ||| S:1829 E:1836 ||| VB
the  ||| S:1836 E:1840 ||| DT
MPO  ||| S:1840 E:1844 ||| NNP
and  ||| S:1844 E:1848 ||| CC
MCI  ||| S:1848 E:1852 ||| NNP
activities  ||| S:1852 E:1863 ||| NNS
and  ||| S:1863 E:1867 ||| CC
moderately  ||| S:1867 E:1878 ||| RB
increased  ||| S:1878 E:1888 ||| VBD
the  ||| S:1888 E:1892 ||| DT
plasma  ||| S:1892 E:1899 ||| JJ
CK  ||| S:1899 E:1902 ||| NNP
level ||| S:1902 E:1907 ||| NN
.  ||| S:1907 E:1909 ||| .
Preliminary  ||| S:1909 E:1921 ||| JJ
observations  ||| S:1921 E:1934 ||| NNS
showed  ||| S:1934 E:1941 ||| VBD
a  ||| S:1941 E:1943 ||| DT
possible  ||| S:1943 E:1952 ||| JJ
link  ||| S:1952 E:1957 ||| NN
between  ||| S:1957 E:1965 ||| IN
MPO  ||| S:1965 E:1969 ||| NNP
activity  ||| S:1969 E:1978 ||| NN
and  ||| S:1978 E:1982 ||| CC
mitochondrial  ||| S:1982 E:1996 ||| JJ
functions ||| S:1996 E:2005 ||| NNS
.  ||| S:2005 E:2007 ||| .
